Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong · Delayed Price · Currency is HKD 19.57
+0.71 (3.76%)
Aug 20, 2026, 4:09 PM HKT
HKG:1877 Market Cap
HKG:1877 has a market cap or net worth of 41.2 billion as of August 20, 2026. Its market cap has decreased by -15.28% in one year.
Market Cap
41.20B
Enterprise Value
43.03B
Revenue
3.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.57
ChartMarket Cap Chart
Since December 24, 2018, HKG:1877's market cap has increased from 18.06B to 41.20B, an increase of 128.18%. That is a compound annual growth rate of 11.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 38.17B | 10.13% |
| Dec 31, 2025 | 34.66B | 39.72% |
| Dec 31, 2024 | 24.81B | -37.28% |
| Dec 29, 2023 | 39.55B | -38.85% |
| Dec 30, 2022 | 64.67B | -7.04% |
| Dec 31, 2021 | 69.57B | -9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 85.29B |
| Akeso | 82.26B |
| RemeGen | 69.08B |
| Genscript Biotech | 64.21B |
| Biocytogen Pharmaceuticals (Beijing) | 58.22B |
| 3SBio | 41.59B |
| Shanghai Henlius Biotech | 35.63B |
| InnoCare Pharma | 29.93B |